Status:
COMPLETED
Efficacy Testing of Crassocephalum Rabens Extract Capsules
Lead Sponsor:
Greenyn Biotechnology Co., Ltd.
Collaborating Sponsors:
Chia Nan University of Pharmacy ＆ Science
Conditions:
Aging
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study is to investigate the improveing effects of the Crassocephalum rebens extract on skin conditions in normal people.
Eligibility Criteria
Inclusion
- Age over 20 years
- Healthy people
Exclusion
- Non-volunteer
- Pregnant and lactating women
- Hypersensitivity to the assigned product
- Diagnosed with skin diseases, liver diseases, kinedy disease, and other severe diseases
- Cosmetic, drug, or food allergies
- Concurrent aesthetic treatments (e.g., intense pulse light, medical peelings, or laser therapy)
- Aceepted aesthetic treatments one month ago before the study
- Chronic sun exposure (over 3 hours/day)
- The members of the research team
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05309161
Start Date
March 14 2022
End Date
June 30 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chia Nan University of Pharmacy ＆ Science
Tainan, Taiwan, 71710